References
Annual Meeting, Am. Psychiat. Assoc., New York City (May 3–7, 1965).
Ayd, F.: Oral contraceptives-psychic effects, note in International Drug Therapy Newsletter. 1, 3–4 (1966).
Bakker, C., and C. Dightman: Psychological factors in fertility control. Fertil. and Steril. 15, 559–567 (1964).
Behrman, S.: Norethindrone, 2 mg: an evaluation. Obstet. and Gynec. 24, 101–105 (1964).
Billig, O., and J. Bradley: Combined shook and corpus luteum hormone therapy. Amer. J. Psychiat. 102, 783–787 (1946).
Blumberg, A., and O. Billig: Hormonal influence upon “puerperal psychosis” and neurotic conditions. Psychiat. Quart. 16, 454 (1942).
Bower, W., and M. Altschule: Use of progesterone in the treatment of postpartum psychosis. New Engl. J. Med. 254, 157–160 (1956).
British Medical Society Symposium: Oral contraceptives. Brit. med. J. 5355, 489 to 491; 5356, 550–551 (1963).
Crocker, K., and W. Stitt: Ovulation inhibitors. Canad. med. Ass. J. 90, 713–716 (1964).
Dingle, J.: Preliminary report on Provest study. Int. J. Fertil. 8, 711–719 (1963).
Dutton, W.: Psychological factors in 155 patients with functional uterine bleeding. Canad. med. Ass. J. 92, 398–405 (1965).
Flowers, C.: Effects of new low dosage form of norethynodrel-mestranol. J. Amer. med. Ass. 188, 1115–1120 (1964).
Gold, J., L. Smith, T. Scommegna, and S. Borushek: The efficiency of Provest in inhibiting ovulation. Int. J. Fertil. 8, 725–735 (1963).
Goldzieher, J.: Study of norethindrone in contraception. J. Amer. med. Ass. 180, 359 (1962).
—: Newer drugs in oral contraception. Med. Clin. N. Amer. 48, 529–545 (1964).
Goodman, L., and A. Gilman: The pharmacological basis of therapeutics. Third Edition. New York: Macmillan 1965.
Gould, J.: Control of ovulation with Provest. Int. J. Fertil. 8, 737–741 (1963).
Guttmacher, A., and G. Perkin: News release, Planned Parenthood—World Population (1965).
Hutcherson, W., H. Schwartz, and L. Smith: Norethindrone with estrogen as an oral contraceptive: A preliminary report. Sth. med. J. (Bgham, Ala.) 56, 1357 to 1362 (1963).
Hyvert, H.: La chlorpromazine traitement des psychoses chroniques. Encephale 45, 617–627 (1956).
Johnson, F.: Enovid therapy in clinical practice. Speech to Wisconsin Society of Obstetrics and Gynecology, Sept. 27, 1962, Racine, Wisc.
Kane, F., R. Daly, J. Ewing, M. Keeler, and C. Flowers: Mood and behavioral change with the use of progestational steroids. Presented at an Annual Meeting, Amer. Psychiat. Assoc., New York City (May 3–7, 1965).
Lebherz, T., and C. Fobes: Management of endometriosis with nor-progesterone. Amer. J. Obstet. Gynec. 81, 102–110 (1961).
Oracon Symposium: Progress in conception control: The sequential regimen, report of a scientific discussion (April 4, 1965). San Francisco. Greenblatt, R. (moderator).
Pollock, G.: Some notes on psychological factors in contraceptive decision, choice and utilization. Paper presented to the symposium on “The control of conception and its implications,” December 26, 1965, at the 132nd annual meeting of The American Association for the Advancement of Science, Berkeley, California.
Pullen, D.: Conovid-E as an oral contraceptive. Brit.med. J. 2, 1016–1019 (1962).
Rice-Wray, E., M. Schulz-Contreras, I. Guerrero, and A. Aranda-Rosell: Long term administration of Norethindrone in fertility control. J. Amer. med. Ass. 180, 355–358 (1962).
—, J. Goldzieher, and A. Aranda-Rosell: Oral progestins in fertility control, a comparative study. Fertil. and Steril. 14, 402–409 (1963).
Ringrove, C.: The emotional responses of married women receiving oral contraceptives. Canad. med. Ass. J. 92, 1207–1209 (1965).
Rovinsky, J.: Clinical effectiveness of a low-dose progestin-estrogen combination. Obstet, and Gynec. 23, 840–850 (1964).
Sapir, P., G. Ryan, N. Shulman, and B. Murawski: Emotional reactions to the contraceptive agent Enovid. Paper given at Annual Meeting, Amer. Soc. for Study of Sterility, San Francisco (April 4, 1965).
Shearman, R.: The mechanism of action of oral contraceptives and their side effects in clinical practice. Med. J. Aust. 1, 68–70 (1965).
Simpson, G., N. Radinger, D. Rochlin, and N. Kline: Enovid in the treatment of psychic disturbances associated with menstruation. Dis. nerv. Syst. 23, 589–590 (1962).
—, D. Rochlin, and N. Kline: Further studies of Enovid in the treatment of psychiatric patients. Dis. nerv. Syst. 25, 484–486 (1964).
Sobrero, J.: Field trial of Provest as contraceptive. Int. J. Fertil. 8, 721–725 (1963).
Swanson, D., A. Barron, A. Floren, and J. Smith: The use of norethynodrel in psychotic females. Amer. J. Psychiat. 120, 1101–1103 (1964).
Tyler, E.: An oral contraceptive, a 4 year study of norethindrone. Obstet. and Gynec. 18, 363–367 (1961).
Zell, J., and W. Crisp: A psychiatric evaluation of the use of oral contraceptives. Obstet. and Gynec. 23, 657–661 (1964).
Author information
Authors and Affiliations
Additional information
This paper was read, in part, at the Symposium “Recent Advances in Psychiatry” sponsored by the Department of Psychiatry, New York Medical College, at Miami Beach, December 1965.
Rights and permissions
About this article
Cite this article
Glick, I.D. Mood and behavioral changes associated with the use of the oral contraceptive agents. Psychopharmacologia 10, 363–374 (1967). https://doi.org/10.1007/BF00403976
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00403976